Triple Antibiotic Plus (G&W Laboratories, Inc.)


Welcome to the PulseAid listing for the Triple Antibiotic Plus drug offered from G&W Laboratories, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: G&W Laboratories, Inc.
NON-PROPRIETARY NAME: Polymyxin B Sulfate, Bacitracin Zinc, Neomycin Sulfate, Pramoxine HCl
SUBSTANCE NAME: POLYMYXIN B SULFATE; BACITRACIN ZINC; NEOMYCIN; PRAMOXINE HYDROCHLORIDE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: TOPICAL
DOSAGE FORM: OINTMENT
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 1998-02-28
END MARKETING DATE: 0000-00-00


Triple Antibiotic Plus HUMAN OTC DRUG Details:

Item DescriptionTriple Antibiotic Plus from G&W Laboratories, Inc.
LABELER NAME: G&W Laboratories, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 10000; 500; 3.5; 10([USP’U]/g; [USP’U]/g; mg/g; mg/g)
START MARKETING DATE: 1998-02-28
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0713-0622_cc87a9af-8a9f-5a57-b08c-f97b773ab743
PRODUCT NDC: 0713-0622
APPLICATION NUMBER: part333B

Other POLYMYXIN B SULFATE; BACITRACIN ZINC; NEOMYCIN; PRAMOXINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
G&W Laboratories, Inc.Triple Antibiotic Plus